Lauri Ivaska
Impact in
- Microbiology top 10%
- Bacterial Infections and Vaccines
-
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
Papers in
- Epidemiology 12
- Respiratory viral infections research 5
- Pneumonia and Respiratory Infections 4
- Infective Endocarditis Diagnosis and Management 4
-
- SARS-CoV-2 and COVID-19 Research 6
- Co-authors
- Ville Peltola (14 shared papers)Jussi Mertsola (4 shared papers)Jussi Niemelä (5 shared papers)Tytti Vuorinen (7 shared papers)Qiushui He (3 shared papers)Alex‐Mikael Barkoff (4 shared papers)Matti Waris (8 shared papers)Johanna Lempainen (9 shared papers)
In The Last Decade
Lauri Ivaska
23 papers receiving 260 citations
Peers
Comparison fields: 5 of 53
- Microbiology 59
- Infectious Diseases 97
- Epidemiology 95
- Applied Microbiology and Biotechnology 5
- Clinical Biochemistry 8
Countries citing papers authored by Lauri Ivaska
This map shows the geographic impact of Lauri Ivaska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauri Ivaska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauri Ivaska more than expected).
Fields of papers citing papers by Lauri Ivaska
This network shows the impact of papers produced by Lauri Ivaska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauri Ivaska. The network helps show where Lauri Ivaska may publish in the future.
Co-authors
The 25 scholars most cited alongside Lauri Ivaska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 35 | |
| 2 | 2022 | 35 | |
| 3 | 2015 | 30 | |
| 4 | 2017 | 24 | |
| 5 | 2013 | 23 | |
| 6 | 2023 | 15 | |
| 7 | 2022 | 13 | |
| 8 | 2015 | 11 | |
| 9 | 2022 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2024 | 10 | |
| 12 | 2016 | 10 | |
| 13 | 2023 | 10 | |
| 14 | 2020 | 9 | |
| 15 | 2024 | 6 | |
| 16 | 2022 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2024 | 2 |
About Lauri Ivaska
Lauri Ivaska is a scholar working on Epidemiology, Infectious Diseases, Public Health, Environmental and Occupational Health, Microbiology and Surgery, having authored 25 papers that have together received 271 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Streptococcal Infections and Treatments (5 papers), Bacterial Infections and Vaccines (5 papers), Respiratory viral infections research (5 papers), Pneumonia and Respiratory Infections (4 papers), Infective Endocarditis Diagnosis and Management (4 papers), Infectious Diseases and Tuberculosis (2 papers) and Viral Infections and Immunology Research (2 papers). The work is most often cited by research in Microbiology (59 citations), Infectious Diseases (97 citations), Epidemiology (95 citations), Applied Microbiology and Biotechnology (5 citations) and Clinical Biochemistry (8 citations). Lauri Ivaska has collaborated with scholars based in Finland, Canada and Brazil. Frequent co-authors include Ville Peltola, Jussi Mertsola, Jussi Niemelä, Tytti Vuorinen, Qiushui He, Alex‐Mikael Barkoff, Matti Waris, Johanna Lempainen, Terho Heikkinen and Riikka Österback. Their work appears in journals such as The Journal of Infectious Diseases, Journal of Infection, Microbiology Spectrum, Frontiers in Immunology and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.